Omniab Inc (OABI)

$1.89 -0.01 (-0.53%)
Market Cap 273.52M
Revenue (ttm) 26.39M
Net Income (ttm) -62.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -235.05%
Debt to Equity Ratio 0.00
Volume 277,000
Avg Vol 593,308
Day's Range N/A - N/A
Shares Out 143.96M
Stochastic %K 64%
Beta 0.13
Analysts Strong Sell
Price Target $7.33

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, EmeryVille, United States
Landomos
Landomos Jan. 8 at 2:20 PM
$OABI $4.00?
0 · Reply
Landomos
Landomos Jan. 8 at 2:10 PM
$OABI This is a buy and hold, loading up. It is starting to get attention
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 30 at 4:59 AM
$OABI RSI: 43.48, MACD: 0.0586 Vol: 0.11, MA20: 1.98, MA50: 1.75 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PayoutPips
PayoutPips Dec. 25 at 8:00 AM
$OABI Market tolerance narrows as uncertainty lingers, since capital markets reward discipline over expansion for its own sake. Shortfalls would likely reprice expectations quickly.
0 · Reply
bearsoil
bearsoil Dec. 24 at 11:14 PM
$OABI 116k block trade at the close After some end of yeartax loss selling looks like a up trend is setting up There has been a few large blocks the past few days
0 · Reply
ils85
ils85 Dec. 22 at 1:48 PM
$OABI loading loading
0 · Reply
bearsoil
bearsoil Dec. 19 at 10:57 PM
$OABI a 1.9 million share trade at the close
0 · Reply
Beroname
Beroname Dec. 18 at 5:31 PM
$OABI test 2.0 and start moving up.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 8:40 PM
$OABI Share Price: $2.08 Contract Selected: Apr 17, 2026 $2.5 Calls Buy Zone: $0.10 – $0.12 Target Zone: $0.19 – $0.23 Potential Upside: 78% ROI Time to Expiration: 120 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Duncan_
Duncan_ Dec. 11 at 8:40 PM
$OABI man you have been spot on here! congratulations. i took a small position earlier today. i am trying to gain a better understanding of the bull case. i followed the insider investor here, from $VKTX. company website was interesting enough. but so little forcast information.
0 · Reply
Latest News on OABI
OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript

Dec 15, 2025, 7:39 PM EST - 24 days ago

OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript

Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

Dec 15, 2025, 4:05 PM EST - 24 days ago

Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

OmniAb to Hold OmniUltra Virtual Investor Event on December 15

Dec 4, 2025, 4:05 PM EST - 5 weeks ago

OmniAb to Hold OmniUltra Virtual Investor Event on December 15

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

Nov 17, 2025, 5:23 PM EST - 7 weeks ago

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

OmniAb, Inc. (OABI) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 11:46 PM EST - 2 months ago

OmniAb, Inc. (OABI) Q3 2025 Earnings Call Transcript

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Nov 4, 2025, 4:05 PM EST - 2 months ago

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

OmniAb to Participate in Three Investor Conferences in November

Oct 16, 2025, 8:00 AM EDT - 3 months ago

OmniAb to Participate in Three Investor Conferences in November

OmniAb to Report Third Quarter 2025 Financial Results on November 4

Oct 14, 2025, 8:00 AM EDT - 3 months ago

OmniAb to Report Third Quarter 2025 Financial Results on November 4

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:00 AM EDT - 4 months ago

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

OmniAb Announces $30 Million Private Placement

Aug 25, 2025, 7:00 AM EDT - 4 months ago

OmniAb Announces $30 Million Private Placement

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 2:24 AM EDT - 5 months ago

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 6, 2025, 4:05 PM EDT - 5 months ago

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

OmniAb to Report Second Quarter 2025 Financial Results on August 6

Jul 16, 2025, 8:00 AM EDT - 6 months ago

OmniAb to Report Second Quarter 2025 Financial Results on August 6

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025, 4:05 PM EDT - 8 months ago

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025, 3:52 AM EDT - 8 months ago

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 4:06 PM EDT - 8 months ago

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025, 4:05 PM EDT - 8 months ago

OmniAb Introduces the xPloration® Partner Access Program

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

May 5, 2025, 1:00 AM EDT - 8 months ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025, 8:00 AM EDT - 9 months ago

OmniAb to Participate in Five Upcoming Investor Conferences

OmniAb Announces Two New Appointments to its Board of Directors

Apr 21, 2025, 8:00 AM EDT - 9 months ago

OmniAb Announces Two New Appointments to its Board of Directors

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 10 months ago

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Mar 18, 2025, 4:05 PM EDT - 10 months ago

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

Feb 24, 2025, 8:00 AM EST - 11 months ago

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

OmniAb to Participate in Two Investor Conferences in March

Feb 3, 2025, 4:57 PM EST - 1 year ago

OmniAb to Participate in Two Investor Conferences in March

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

Jan 31, 2025, 11:09 AM EST - 1 year ago

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

Dec 16, 2024, 4:15 PM EST - 1 year ago

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 9:53 PM EST - 1 year ago

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 12, 2024, 4:05 PM EST - 1 year ago

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

OmniAb to Participate in Two Investor Conferences in November

Oct 30, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in November

OmniAb to Report Third Quarter 2024 Financial Results on November 12

Oct 22, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report Third Quarter 2024 Financial Results on November 12

OmniAb to Participate in Two Investor Conferences in September

Aug 26, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in September

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:28 AM EDT - 1 year ago

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 8, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

Aug 6, 2024, 8:25 AM EDT - 1 year ago

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

FIP FTAI IMVT PRPL REAL RICK

OmniAb to Report Second Quarter 2024 Financial Results on August 8

Jul 25, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report Second Quarter 2024 Financial Results on August 8

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

Jun 3, 2024, 4:05 PM EDT - 1 year ago

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

OmniAb to Participate in the Jefferies Global Healthcare Conference

May 20, 2024, 8:05 AM EDT - 1 year ago

OmniAb to Participate in the Jefferies Global Healthcare Conference

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

May 15, 2024, 4:05 PM EDT - 1 year ago

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

May 10, 2024, 4:33 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

May 9, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

OmniAb to Participate in Five Investor Conferences in May

May 1, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Investor Conferences in May

OmniAb to Report First Quarter 2024 Financial Results on May 9

Apr 22, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report First Quarter 2024 Financial Results on May 9

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

Apr 15, 2024, 8:31 AM EDT - 1 year ago

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

THAR

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 7:38 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 20, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

Feb 26, 2024, 8:00 AM EST - 2 years ago

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Dec 14, 2023, 4:30 PM EST - 2 years ago

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

Nov 14, 2023, 12:44 PM EST - 2 years ago

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

Nov 9, 2023, 5:55 PM EST - 2 years ago

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 9, 2023, 8:00 AM EST - 2 years ago

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Landomos
Landomos Jan. 8 at 2:20 PM
$OABI $4.00?
0 · Reply
Landomos
Landomos Jan. 8 at 2:10 PM
$OABI This is a buy and hold, loading up. It is starting to get attention
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 30 at 4:59 AM
$OABI RSI: 43.48, MACD: 0.0586 Vol: 0.11, MA20: 1.98, MA50: 1.75 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PayoutPips
PayoutPips Dec. 25 at 8:00 AM
$OABI Market tolerance narrows as uncertainty lingers, since capital markets reward discipline over expansion for its own sake. Shortfalls would likely reprice expectations quickly.
0 · Reply
bearsoil
bearsoil Dec. 24 at 11:14 PM
$OABI 116k block trade at the close After some end of yeartax loss selling looks like a up trend is setting up There has been a few large blocks the past few days
0 · Reply
ils85
ils85 Dec. 22 at 1:48 PM
$OABI loading loading
0 · Reply
bearsoil
bearsoil Dec. 19 at 10:57 PM
$OABI a 1.9 million share trade at the close
0 · Reply
Beroname
Beroname Dec. 18 at 5:31 PM
$OABI test 2.0 and start moving up.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 8:40 PM
$OABI Share Price: $2.08 Contract Selected: Apr 17, 2026 $2.5 Calls Buy Zone: $0.10 – $0.12 Target Zone: $0.19 – $0.23 Potential Upside: 78% ROI Time to Expiration: 120 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Duncan_
Duncan_ Dec. 11 at 8:40 PM
$OABI man you have been spot on here! congratulations. i took a small position earlier today. i am trying to gain a better understanding of the bull case. i followed the insider investor here, from $VKTX. company website was interesting enough. but so little forcast information.
0 · Reply
PlannedTrading101
PlannedTrading101 Dec. 11 at 7:32 PM
$OABI Accumulated for a few months. Still little to no attention here. Lots of room to still run IMO
0 · Reply
Duncan_
Duncan_ Dec. 11 at 5:42 PM
$OABI what is the bull case here? i see the chart is moving. what is the financial case here. sales were down. Are they now expected to rise?
0 · Reply
PlannedTrading101
PlannedTrading101 Dec. 11 at 4:40 PM
$OABI Let's get to 2.50+ now
0 · Reply
PlannedTrading101
PlannedTrading101 Dec. 11 at 4:40 PM
$OABI People still sleeping on this one!
0 · Reply
MrEsKurr
MrEsKurr Dec. 9 at 12:26 AM
$OABI sold at the closing price for 5.8% gain.
1 · Reply
JoeDeMencia
JoeDeMencia Dec. 5 at 2:33 PM
$OABI is this another bull trap or does it have some legs finally?
0 · Reply
bearsoil
bearsoil Dec. 4 at 9:08 PM
$OABI nice trading at the close Great chart Good year ahead
0 · Reply
MrEsKurr
MrEsKurr Dec. 3 at 9:33 PM
$OABI im only it at 1.86 closing price .. this also looks great.
1 · Reply
PlannedTrading101
PlannedTrading101 Nov. 24 at 4:22 PM
$OABI Looking solid!
0 · Reply
stockanalysis_
stockanalysis_ Nov. 24 at 1:16 PM
Premarket Losers: $CLSD $TWNP $PMN $SHPH $OABI Bookmark this page: https://stockanalysis.com/markets/premarket/losers/?ref=saveontrading
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:39 PM
$OABI $OBIO $OCGN 🔥
0 · Reply
Landomos
Landomos Nov. 21 at 8:13 PM
$OABI Starting to gently edge up. $4:00 would not be far fetched soon.
0 · Reply